BioVie Inc BIVI:NASDAQ

Last Price$5.22NASDAQ Previous Close - Last Trade as of 4:00PM ET 12/06/21

Today's Change-0.12(2.25%)
Bid (Size)$4.00 (1)
Ask (Size)$5.22 (1)
Day Low / High$5.11 - 5.44
Volume37.1 K
 

Read more news Recent News

--B. Riley Lowers BioVie's PT to $27 from $50 to Reflect Continued Expansion in Research, Development Spend, Stretched Out Commercialization Timelines; Keeps Buy Rating
9:39AM ET 11/30/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

BioVie Secures FDA Approval for Phase 2 Trial of Potential Parkinson's Disease Treatment; Shares Climb
12:14PM ET 10/26/2021 MT Newswires

BioVie (BIVI) said Tuesday the US Food and Drug Administration approved its plan to start a phase 2 study to assess its NE3107 product candidate's...

BioVie Closes Common Stock Offering
2:31PM ET 8/11/2021 MT Newswires

BioVie (BIVI) on Wednesday announced the closing of a common stock public offering raising gross proceeds of $20 million. The clinical-stage biotechnology...

Top Midday Decliners
1:53PM ET 8/09/2021 MT Newswires

Axsome Therapeutics (AXSM) reported a wider net loss in Q2, sending shares down 45% by Monday afternoon as trading volume surged to 7.8 million compared...

View all Commentary and Analysis

U.S. IPO Week Ahead: The Spring IPO Market Starts To Thaw In An 8 IPO Week
8:25AM ET 3/13/2021 Seeking Alpha

Wall Street Breakfast: What Moved Markets
8:26AM ET 3/06/2021 Seeking Alpha

Company Profile

Business DescriptionBioVie, Inc. is a biopharmaceutical company, which discovers, develops and commercializes drug therapies for liver disease. It focuses on BIV201, which treats ascites due to chronic liver cirrhosis. The company was founded on April 10, 2013 and is headquartered in Santa Monica, CA. View company web site for more details
Address2120 Colorado Avenue
Santa Monica, California 90404
Phone+1.312.283.5793
Number of EmployeesN/A
Recent SEC Filing12/01/20218-K
President, Chief Executive Officer & DirectorCuong Viet Do
Chief Financial Officer & SecretaryJoanne Wendy Kim
Chief Medical OfficerJoseph M. Palumbo
Executive Vice President-Liver Disease ProgramJonathan Adams

Company Highlights

Price Open$5.33
Previous Close$5.22
52 Week Range$5.11 - 46.10
Market Capitalization$130.3 M
Shares Outstanding25.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$6.56
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-1,150.48%

Analyst Ratings as of 11/29/2021

Buy
1
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset